We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Motif Bio Plc | LSE:MTFB | London | Ordinary Share | GB00BVVT4H71 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.50 | 0.40 | 0.55 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMMTFB
RNS Number : 3015R
Motif Bio PLC
08 December 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------- 1. Identity of the issuer or Motif Bio plc the underlying issuer of existing shares to which voting rights are attached: (ii) ------------------------------------------------------------- --------------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ------------------------------------------------------------------------------------------------------------ An acquisition or disposal of voting rights -------------------------------------------------------------------------------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached -------------------------------------------------------------------------------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments -------------------------------------------------------------------------------------------------------- An event changing the breakdown of voting rights -------------------------------------------------------------------------------------------------------- Other (please Issue of ADSs on Initial Public Offering Y specify): on Nasdaq --------------------------------------------------------- --------------------------------------------- 3. Full name of person(s) Sabby Healthcare Master Fund, subject to the Ltd notification obligation: Sabby Management, LLC (iii) Hal Mintz ----------------------------------------------------------- ----------------------------------------------- 4. Full name of shareholder(s) Sabby Healthcare Master Fund, (if different from 3.):(iv) Ltd ----------------------------------------------------------- ----------------------------------------------- 5. Date of the transaction 23 November 2016 and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------- ----------------------------------------------- 6. Date on which issuer 30 November 2016 notified: ----------------------------------------------------------- ----------------------------------------------- 7. Threshold(s) that is/are >9% crossed or reached: (vi, vii) ----------------------------------------------------------- ----------------------------------------------- 8. Notified details: ------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------ ------------------------------ --------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights ------------ -------------- -------------- ------------- --------------------- ------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------ ------------ ------------ ------------- -------- ----------- -------- --------- B: Qualifying Financial Instruments ------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. -------------- ------------- ----------------------------- -------------------- ------------------- American Depositary Shares 17,191,980 9.52 -------------- ------------- ----------------------------- -------------------- ------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) ------------- ------------- ------------- -------------- --------------------- ------------------- Nominal Delta ------------- ------------- ------------- -------------- --------------------- -------- --------- Total (A+B+C) ------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights --------------------------------------------- -------------------------------------------------------- 17,191,980 9.52 --------------------------------------------- -------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) --------------------------------------------------------------------------------- Hal Mintz is manager of Sabby Management LLC, which serves as the investment manager of Sabby Healthcare Master Fund Ltd. Each of Sabby Management, LLC and Hal Mintz disclaims beneficial ownership over the securities listed except to the extent of their pecuniary interest therein. Proxy Voting: --------------------------------------------------------------------------------- 10. Name of the proxy holder: ------------------------------------------------------------- ------------------ 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- ------------------ 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- ------------------ 13. Additional information: ------------------------------------------------------------- ------------------ 14. Contact name: Robert Grundstein ------------------------------------------------------------- ------------------ 15. Contact telephone number: 646-307-4500 ------------------------------------------------------------- ------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLLIFSDFLLTIIR
(END) Dow Jones Newswires
December 08, 2016 02:45 ET (07:45 GMT)
1 Year Motif Bio Chart |
1 Month Motif Bio Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions